Login
Enter your username or email address.
Enter the password that accompanies your username.

Request new password

product logo

Brainmaster country menu

  • Home
  • Brain Master
  • Ask the Experts

Back to video list Back to Home

How long should we stay with escitalopram when treating GAD, with regard to relapse prevention?

You may also like

Alzheimer's Disease
Article

β-amyloid remains a compelling target

Migraine
Satellite symposium Article

New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention

Migraine
Satellite symposium Article

Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world

Mental Health
Congress highlights Article

The evolving landscape of transdiagnostic psychiatry

Progress in Mind South East Asia

HCP Access Verification Required

To gain access, please provide details to verify you are a healthcare professional.

Register Login

If you are not located in South East Asia click here.

Brought to you by

Lundbeck

© 2022 Brain Master

SEA Brain Master

Disclaimer and privacy statement

Live webinars are hosted on third party platforms

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue